Alveolar Soft Part Sarcoma (ASPS)/Renal Cell Carcinoma (RCC), Xp11.23 (TFE3), FISH, Tissue
SARS-CoV-2 (COVID-19) Coronavirus, Molecular
Felbamate, Serum
Gene Expression Profile for Cutaneous Melanoma, DermTech (DecisionDx®-SCC), Pigmented Lesion Assay (PLA), myPath® Melanoma, Merlin™ Test
Friedreich Ataxia Repeat Expansion, FXN (frataxin) Gene Analysis
Phenylephrine, Urine or Serum
IGH Somatic Hypermutation Analysis, B-Cell Chronic Lymphocytic Leukemia (B-CLL)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
Oncomine™ Dx Express™ Test for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
Oncomine™ Dx Express™ Test for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring
Medical Test
Additional ICD10
Access to
Oncomine™ Dx Express™ Test for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring
is restricted.
Sign up now
Loading...